Fink Jeffrey Arvin 4
4 · Lipocine Inc. · Filed Jun 10, 2020
Insider Transaction Report
Form 4
Lipocine Inc.LPCN
Fink Jeffrey Arvin
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-06-10$0.96/sh+22,000$21,184→ 22,000 totalExercise: $0.96From: 2021-06-10Exp: 2030-06-10→ Common Stock (22,000 underlying)
Footnotes (1)
- [F1]100% vesting one year from date of grant